0001209191-21-071193.txt : 20211223 0001209191-21-071193.hdr.sgml : 20211223 20211223210016 ACCESSION NUMBER: 0001209191-21-071193 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211222 FILED AS OF DATE: 20211223 DATE AS OF CHANGE: 20211223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cohen Chad M CENTRAL INDEX KEY: 0001524314 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38957 FILM NUMBER: 211518709 MAIL ADDRESS: STREET 1: C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION STREET 2: 1551 EASTLAKE AVENUE E STE 200 CITY: SEATTLE STATE: WA ZIP: 98101 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Adaptive Biotechnologies Corp CENTRAL INDEX KEY: 0001478320 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 270907024 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1165 EASTLAKE AVE E CITY: SEATTLE STATE: WA ZIP: 98109 BUSINESS PHONE: 206-659-0067 MAIL ADDRESS: STREET 1: 1165 EASTLAKE AVE E CITY: SEATTLE STATE: WA ZIP: 98109 FORMER COMPANY: FORMER CONFORMED NAME: Adaptive TCR Corp DATE OF NAME CHANGE: 20091209 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-12-22 0 0001478320 Adaptive Biotechnologies Corp ADPT 0001524314 Cohen Chad M C/O ADAPTIVE BIOTECHNOLOGIES CORP. 1165 EASTLAKE AVENUE E SEATTLE WA 98109 0 1 0 0 Chief Financial Officer Common Stock 2021-12-22 4 M 0 10000 7.27 A 31604 D Common Stock 2021-12-22 4 S 0 10000 30.00 D 21604 D Stock Option (Right to Buy) 7.27 2021-12-22 4 M 0 10000 0.00 D 2029-02-07 Common Stock 10000 80000 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2020. The options vested with respect to 1/4 of such shares on January 1, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested. /s/ Chad Cohen by Eric Billings, Attorney-in-Fact 2021-12-23